Whither recombinant human growth hormone?

Editorial

C S Mantzoros et al. Ann Intern Med. 1996.

. 1996 Dec 1;125(11):932-4.

doi: 10.7326/0003-4819-125-11-199612010-00010.

No abstract available

Comment on

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.
Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D. Waters D, et al. Ann Intern Med. 1996 Dec 1;125(11):865-72. doi: 10.7326/0003-4819-125-11-199612010-00001. Ann Intern Med. 1996. PMID: 8967666 Clinical Trial.
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB. Schambelan M, et al. Ann Intern Med. 1996 Dec 1;125(11):873-82. doi: 10.7326/0003-4819-125-11-199612010-00002. Ann Intern Med. 1996. PMID: 8967667 Clinical Trial.
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.
Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A. Baum HB, et al. Ann Intern Med. 1996 Dec 1;125(11):883-90. doi: 10.7326/0003-4819-125-11-199612010-00003. Ann Intern Med. 1996. PMID: 8967668 Clinical Trial.